Literature DB >> 28101741

Anti-hyperuricemic effect of taxifolin in cultured hepatocytes and model mice.

Shin-Ichi Adachi1, Ken-Ichi Nihei2,3, Yoshiyuki Ishihara4, Fumiaki Yoshizawa2,3, Kazumi Yagasaki5.   

Abstract

Hyperuricemia is recognized as an important risk factor for gout. High dietary intake of purine-rich foods such as meats and sea foods increases uric acid (UA) levels in the blood. Taxifolin present in Siberian larch and strawberries has been reported to possess health promoting activities including anti-oxidant effect. In this study, we examined anti-hyperuricemic effect of taxifolin in both cultured hepatocytes and hyperuricemic model mice. In cultured AML12 hepatocytes, taxifolin significantly suppressed UA production dose- and time-dependently. In mice with hyperuricemia induced by concurrent administration of guanosine-5'-monophosphate and inosine-5'-monophosphate, oral administration of taxifolin suppressed the increases in plasma and liver UA levels. In addition, it also suppressed hepatic xanthine oxidase (XO) activity. Thus, anti-hyperuricemic effect of taxifolin could be explained, at least partly, by suppressing UA production via inhibition of XO activity in the liver. These results suggest that taxifolin possesses a potent hypouricemic effect and it could be a potential candidate for an anti-hyperuricemic phytochemical.

Entities:  

Keywords:  AML12 hepatocyte; Hyperuricemia; Taxifolin; Uric acid

Year:  2017        PMID: 28101741      PMCID: PMC5366969          DOI: 10.1007/s10616-016-0061-4

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  20 in total

1.  Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice.

Authors:  Cai-Ping Wang; Xing Wang; Xian Zhang; Yun-Wei Shi; Lei Liu; Ling-Dong Kong
Journal:  J Pharm Pharm Sci       Date:  2010       Impact factor: 2.327

2.  Profiling polyphenols of two diploid strawberry (Fragaria vesca) inbred lines using UHPLC-HRMS(n.).

Authors:  Jianghao Sun; Xianjin Liu; Tianbao Yang; Janet Slovin; Pei Chen
Journal:  Food Chem       Date:  2013-09-12       Impact factor: 7.514

3.  Taxifolin mitigates oxidative DNA damage in vitro and protects zebrafish (Danio rerio) embryos against cadmium toxicity.

Authors:  Krishnan Manigandan; Richard L Jayaraj; Kaliaperumal Jagatheesh; Namasivayam Elangovan
Journal:  Environ Toxicol Pharmacol       Date:  2015-05-08       Impact factor: 4.860

4.  Anti-inflammatory activity of taxifolin.

Authors:  M B Gupta; T N Bhalla; G P Gupta; C R Mitra; K P Bhargava
Journal:  Jpn J Pharmacol       Date:  1971-06

5.  Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial.

Authors:  Yuanlu Shi; Gary Williamson
Journal:  Br J Nutr       Date:  2016-01-20       Impact factor: 3.718

6.  Inhibition of melanin production by a combination of Siberian larch and pomegranate fruit extracts.

Authors:  Ganesh Diwakar; Jatinder Rana; Jeffrey D Scholten
Journal:  Fitoterapia       Date:  2012-06-17       Impact factor: 2.882

7.  Resveratrol inhibits hepatoma cell invasion by suppressing gene expression of hepatocyte growth factor via its reactive oxygen species-scavenging property.

Authors:  Daiki Miura; Yutaka Miura; Kazumi Yagasaki
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study.

Authors:  N Babio; M A Martínez-González; R Estruch; J Wärnberg; J Recondo; M Ortega-Calvo; L Serra-Majem; D Corella; M Fitó; E Ros; N Becerra-Tomás; J Basora; J Salas-Salvadó
Journal:  Nutr Metab Cardiovasc Dis       Date:  2014-10-31       Impact factor: 4.222

9.  Hypouricemic action of selected flavonoids in mice: structure-activity relationships.

Authors:  Shi-Fu Mo; Feng Zhou; Yao-Zhong Lv; Qing-Hua Hu; Dong-Mei Zhang; Ling-Dong Kong
Journal:  Biol Pharm Bull       Date:  2007-08       Impact factor: 2.233

10.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

View more
  6 in total

Review 1.  New Insights into the Efficacy of Aspalathin and Other Related Phytochemicals in Type 2 Diabetes-A Review.

Authors:  Christo J F Muller; Elizabeth Joubert; Nireshni Chellan; Yutaka Miura; Kazumi Yagasaki
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

2.  Comparative effects of quercetin, luteolin, apigenin and their related polyphenols on uric acid production in cultured hepatocytes and suppression of purine bodies-induced hyperuricemia by rutin in mice.

Authors:  Shin-Ichi Adachi; Mifuyu Oyama; Shinji Kondo; Kazumi Yagasaki
Journal:  Cytotechnology       Date:  2021-02-02       Impact factor: 2.040

3.  Hyperuricemia in type 2 diabetic model KK-Ay/Ta mice: a potent animal model with positive correlation between insulin resistance and plasma high uric acid levels.

Authors:  Shin-Ichi Adachi; Fumiaki Yoshizawa; Kazumi Yagasaki
Journal:  BMC Res Notes       Date:  2017-11-07

4.  Antihyperuricemic Effect of Urolithin A in Cultured Hepatocytes and Model Mice.

Authors:  Shin-Ichi Adachi; Kazunori Sasaki; Shinji Kondo; Wataru Komatsu; Fumiaki Yoshizawa; Hiroko Isoda; Kazumi Yagasaki
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

Review 5.  Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Authors:  Iveta Bernatova; Silvia Liskova
Journal:  Antioxidants (Basel)       Date:  2021-03-16

6.  Antidiabetic Effect of Taxifolin in Cultured L6 Myotubes and Type 2 Diabetic Model KK-Ay/Ta Mice with Hyperglycemia and Hyperuricemia.

Authors:  Shinji Kondo; Shin-Ichi Adachi; Fumiaki Yoshizawa; Kazumi Yagasaki
Journal:  Curr Issues Mol Biol       Date:  2021-09-26       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.